Table 1.
Clinical characteristics of all subjects at baseline, also stratified by glucose tolerance status at baseline
| All | NGT | IGT | P-value (NGT-IGT) | |
|---|---|---|---|---|
| N | 138 | 117 | 21 | |
| Age (years) | 40.5 ± 6.5 | 40.2 ± 6.7 | 42.5 ± 5.0 | n.s. |
| Sex (% male) | 60 (43 %) | 51 (44 %) | 9 (43 %) | n.s. |
| Weight (kg) | 77.1 ± 13.0 | 76.8 ± 12.8 | 79.5 ± 14.4 | n.s. |
| BMI (kg/m2) | 25.2 ± 3.4 | 25.0 ± 3.3 | 26.7 ± 3.7 | 0.049 |
| Waist (cm) | 88.9 ± 10.4 | 88.3 ± 10.1 | 92.6 ± 11.4 | n.s. |
| Waist/hip circumference ratio | 0.87 ± 0.1 | 0.86 ± 0.1 | 0.89 ± 0.1 | n.s. |
| Fat percent (%) | 25.8 ± 7.8 | 25.2 ± 8.0 | 28.8 ± 6.0 | 0.058 |
| Systolic blood pressure (mmHg) | 118 ± 11 | 118 ± 10 | 122 ± 14 | 0.098 |
| Diastolic blood pressure (mmHg) | 75 ± 9 | 75 ± 9 | 79 ± 10 | 0.081 |
| Currently smoking | 13 (10 %) | 13 (12 %) | 0 (0 %) | n.s. |
| High physical activity | 46 (35 %) | 43 (38 %) | 3 (17 %) | 0.074 |
| High heredity for T2D | 78 (59 %) | 68 (61 %) | 10 (48 %) | 0.092 |
NGT = normal glucose tolerance. IGT = impaired glucose tolerance. Data are means ± standard deviation. P-values below 0.1 are given numerically, otherwise stated as not significant (n.s.)